Real-time enrollment status for this juvenile myoclonic epilepsy clinical trial
Current Status
Recruiting
Checked: October 6, 2026 at 10:57 PM UTC
| NCT Number | NCT07723963 |
| Recruiting Status | Recruiting |
| Condition | Juvenile Myoclonic Epilepsy |
| Phase | PHASE2 |
| Target Enrollment | 260 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Jazz Pharmaceuticals |
| Last Updated on CT.gov | October 6, 2026 (22 hours ago) |
As of October 6, 2026: Clinical trial NCT07723963 is currently recruiting participants. This phase2 study for juvenile myoclonic epilepsy is actively seeking new participants at 20 locations across the United States. The study is sponsored by Jazz Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07723963 is actively recruiting participants as of October 6, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07723963 was last updated 22 hours ago (October 6, 2026). HelloStudys verifies this status automatically.